Arsanis and X4 Pharmaceuticals Agree to Merger
– Merger Expected to Create NASDAQ-listed, Late-stage Biopharmaceutical Company Focused on Rare Diseases and Cancer – – Phase 3 Clinical […]
Plinabulin Newly Granted Patent Covering Method of Use in Prevention of Neutropenia
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development […]
Axsome Therapeutics Expands Loan Agreement with Silicon Valley Bank Providing Additional Growth Capital Related to AXS-12 Product Candidate
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
Secoo Holding Limited to Report Third Quarter 2018 Financial Results on Tuesday, December 4, 2018
-Earnings Call Scheduled for 8:00 a.m. ET on December 4, 2018- BEIJING, Nov. 27, 2018 (GLOBE NEWSWIRE) — Secoo Holding […]
Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split
NEW YORK, Nov. 27, 2018 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a clinical-stage biopharmaceutical company focused on […]
Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy
Data Published in Human Molecular Genetics Demonstrate that a Highly Specific Inhibitor of Myostatin Activation Effectively Increases Muscle Mass and […]
Bellicum Pharmaceuticals to Host Analyst and Investor Event and Webcast on Monday, December 3
HOUSTON, Nov. 27, 2018 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for […]
Akoustis CEO to Present at the LD Micro 11th Annual Main Event Conference on December 4, 2018 at 11:30 am ET
Charlotte, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented bulk […]
Evogene’s Leading Insect Control Genes Demonstrate Effectiveness Against Insects with Resistance to Current Commercial Solutions
External laboratory testing proves efficacy of insect control genes in feeding experiments, indicating new Modes-of-Action REHOVOT, Israel, Nov. 27, 2018 […]
TSX News -
RioCan Provides Update on RioCan Living
RioCan’s residential brand, RioCan Living prepares to commence leasing of two purpose-built rental communities before end of 2018 TORONTO, Nov. […]
